Sex differences in angiotensin II responses contribute to a differential regulation of cox-mediated vascular dysfunction during aging

Exp Gerontol. 2016 Dec 1:85:71-80. doi: 10.1016/j.exger.2016.09.020. Epub 2016 Oct 3.

Abstract

Aging is a cardiovascular risk factor partially related to activation of the Renin-Angiotensin System (RAS). RAS activation is also influenced by sex. In this regard, our study aims to determine whether sex-associated differences in RAS contribute to a differential regulation of vascular aging and associated dysfunction. Male and female outbreed CD-1 mice were studied at 3 and 12months of age (M). Contribution of RAS was determined by treating mice from 3M to 12M with the AngII type 1 receptor blocker losartan (0.6g/L in the drinking water). At 12M, contractions to AngII were higher in males compared to females (P<0.05). This effect was paralleled by a decrease in AngII type 2 receptors in 12M males. Aging also diminished ACh relaxation in males, but did not modify female responses. Treatment of aortas with indomethacin (10μM) restored the impaired endothelium-dependent relaxation in 12M males, suggesting an increase of cyclooxygenase (COX)-derived vasoconstrictors in aged males. Chronic treatment of mice with losartan also improved endothelium-dependent relaxation. Besides, losartan significantly decreased COX-2 expression and activity in 12M male, with a minor effect in aged females. Aging increases AngII contraction and induces endothelial dysfunction differently in males and females. In aged males, RAS contributed to increased COX-2 expression and activity, which in turn may lead to vascular dysfunction.

Keywords: Endothelial dysfunction; Prostaglandin; Renin-angiotensin system; Sex-differences; Vascular aging.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aging / physiology*
  • Angiotensin II / metabolism*
  • Angiotensin II Type 1 Receptor Blockers / pharmacology*
  • Animals
  • Cyclooxygenase 2 / metabolism
  • Endothelium, Vascular / drug effects
  • Female
  • Indomethacin / pharmacology
  • Losartan / pharmacology
  • Male
  • Mice
  • Oxidative Stress / drug effects
  • Prostaglandins / metabolism*
  • Renin-Angiotensin System / drug effects*
  • Sex Factors*
  • Vasodilation / drug effects

Substances

  • Angiotensin II Type 1 Receptor Blockers
  • Prostaglandins
  • Angiotensin II
  • Ptgs2 protein, mouse
  • Cyclooxygenase 2
  • Losartan
  • Indomethacin